NCT04268095 is a NA clinical trial of Dressing protocol in Trigger Finger Disorder, sponsored by Itay Ashkenazi.

Who is sponsoring NCT04268095?

NCT04268095 is sponsored by Itay Ashkenazi.

What drugs are being tested in NCT04268095?

Interventions in NCT04268095: Dressing protocol.

What condition does NCT04268095 study?

NCT04268095 studies Trigger Finger Disorder, Carpal Tunnel Syndrome, Ganglion.

Is NCT04268095 still recruiting?

NCT04268095 is currently completed. Last updated 6 April 2021.

Last reviewed 2021-04-06 · How we verify

NCT04268095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post Operative Dressing After Clean Elective Hand Surgery

Completed NA Last updated 6 April 2021

What this trial tests

NA trial testing Dressing protocol in Trigger Finger Disorder in 60 participants. Completed in 1 February 2021.

Timeline

31 December 2019

Primary endpoint
31 December 2020

1 February 2021

Quick facts

Lead sponsor	Itay Ashkenazi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	60
Start date	31 December 2019
Primary completion	31 December 2020
Estimated completion	1 February 2021
Sites	1 location across Israel

Drugs / interventions tested

Dressing protocol

Conditions studied

Trigger Finger Disorder — all drugs for Trigger Finger Disorder →
Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →
Ganglion — all drugs for Ganglion →

Sponsor

Itay Ashkenazi

Who can join

18 and older, any sex, with Trigger Finger Disorder or Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Very little has been published about the optimal post operative dressing protocol, and no practical conclusion has emerged from a meta-analysis published in 2013. Even fewer studies focused on that topic specifically in hand surgery. Nevertheless, the functional impairment due to a dressing in the hand is much greater than anywhere else, due to the constant use of hands in daily life activities. Yet, habits differs widely following surgeon's preference, from daily change with application of an antimicrobial unguent, to unchanged dressing until the first follow up consultation after 2 weeks, to complete removal of the dressing and basic soap and water cleaning at postoperative day (POD) 1. Those varying recommendations have functional and logistical implication for the patients, especially the elderlies, for whom autonomy is a fragile status that can be dramatically impaired by such protocols. The goal of this study is to define which post operative dressing protocol is optimal in terms of wound complications (disunion, infection)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04268095 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Itay Ashkenazi
Last refreshed: 6 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04268095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing